1McCullough PA,Hollander JE,Nowak RM et al.Uncovering heart failure in patients with a history of pulmonary disease:rationale for the early use of B-type natriuretic peptide in the emergency department.Acad Emerg Med,2003;10(3):198～204
2Maisel AS,Koon J,Krishnaswany P et al.Utility of B-type natriuretic peptide as a rapid point-of-care test for screening patients undergoing echocardiography to determine left vehicular dysfunction.Am Heart J,2001;141:367～374
3Morrison LK,Harrison A,Krishnaswamy P et al.Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.AmColl Cardiol,2002 16;39(2):202～209
4Maggioni A,Anand I,Gottlieb S et al.Effects of valsartan on morbidity and mortality in patients with heart failure not receiving ACE-inhibitors.J Am Coll Cardial,2002
5Remme WJ,Swedberg K.For the Task force for the diagnosis and treatment of Chronic Heart Failure:Guildlines for the diagnosis and treatment of chronic heart failure.Eur Heart J,2001;22:1527-1560
6Dao Q,Kr-ishnaswamy P,Kazanegra R et al.Utility of Btype natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.J Am Coll Cardiol,2001;37(2):379-385
7Pesola GR.The Use of B-type natriuretic Peptide(BNP)to distinguish heart failure from lung disease in patients presenting with dyspnea to the emergency department.Acad Emerg Med,2003;10(3):275-277
8Lubien e,Demaria a,Kazanegra R et al.Utility of B-type natriuretic peptide in detecting diastolic dysfunction:comparison with Dopple velocity recordings.Circulation,2002;105:595-601
9Latini R,Maggioni AP,Masson S.What dose the future hold for BNP in cardiology? Heart 2001;86:601-602
10Cheng V,Kazanagra R,Garcia A et al.A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure:a pilot study.J Am Coll Cardiol,2001;37(2):386-391
4Maeda K,Tsntamoto T,Wada A,et al.High levels of plasma brain natriuretic peptide ang interleukin6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure[J].J AM Coll Cardiol,2000,36(5):1587-1593.
5Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B - type natriuretic peptide in the emergency diagnosis of heart failure[ J]. N En - gl J Med ,2002,347 : 161 - 167.
6Weber, Harem C. Role of B - type natriuretie peptide and NT - proBNP[J], in clinical reutine,2006,92:843 - 849.
7KjaerA, Hesse B. Heart failure and neuroendocfine aetivation:diag - nostie,prognostic and therapeutic perspectives[ J ]. ClinPhysiol, 2001,21:661 - 672.
8Schou M,Dalsgaard MK.Clemmesen Ov et al. Kidneys extract BNP and NT-proBNP in healthy young men [J]. Appl Physiol,2005 ,99(5): 1676-1680.
9Michielsen EC,Bakker]A,Kimmenade RR,et al. The diagnostic value of serum and urinary NT-proBNP for heart failure[J]. Ann Clin Biochem , 2008,45 (pt4): 389-394.
10Palmer SC, Endre ZH, Richards AM, et al. Characterization of NT-proBNP in human urine[J]. Clin Chern , 2009,55(6):1126-1134.
